Randomized Controlled Trial of Yoga and Exercise in Multiple Sclerosis
Neurol 62:2058-2064, Oken,B.S.,et al, 2004
Impact of Aerobic Training on Fitness and Quality of Life in Multiple Sclerosis
Ann Neurol 39:432-441, 4221996., Petajan,J.H.,et al, 1996
Uhthoff's Symptom in Disorders of the Anterior Visual Pathways
Neurol 44:1036-1038, Lepore,F.E., 1994
Uhthoff's Symptom in Optic Neuritis:Relationship to Magnetic Resonance Imaging & Development of Multiple Sclerosis
Ann Neurol 30:180-184, Scholl,G.B.,et al, 1991
Multiple Sclerosis:Early Prognostic Guidelines
Arch Phys Med Rehab 62:54-58, Kraft,G.H.,et al, 1981
Prodromal Symptoms of Multiple Sclerosis in Primary Care
Ann Neurol 83:1162-1173, Disanto,G.,et al, 2018
Neuropsychiatric Syndromes Associated With Multiple Sclerosis
J Neurol 254:II/73-II/76, Feinstein,A., 2007
Premenstrual Multiple Sclerosis Pseudoexacerbations: Role of Body Temperature and Prevention With Aspirin
Arch Neurol 63:1005-1008, Wingerchuk,D.M. &Rodriguez,M., 2006
Modafinil for Fatigue in MS
Neurol 64:1139-1143, Stankoff,B.,et al, 2005
Self Reported Stressful Life Events and Exacerbations in Multiple Sclerosis:Prospective Study
BMJ 327:646-649, Beljevac,D.,et al, 2003
Efficacy and Safety of Modafinil (Provigil) for the Treatment of Fatigue in Multiple Sclerosis: A Two Centre Phase 2 Study
JNNP 72:179-183,150, Rammohan,K.W.,et al, 2002
Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management
The Neurologist 8:227-236, Frohman,E.,et al, 2002
Psychological Stress and the Subsequent Appearance of New Brain MRI Lesions in MS
Neurol 55:55-61, Mohr,D.C. et al, 2000
The Relationship of MS to Physical Trauma and Psychological Stress, Report of the Therapeutics and Technology Assessment Subcommittee of the AAN
Neurol 52:1737-1745, Goodin,D.S.,et al, 1999
Gastric Tolerance of High-Dose Pulse Oral Prednisone in Multiple Sclerosis
Neurol 53:2093-2096, Metz,L.M.,et al, 1999
Management of Patients Receiving Interferon Beta-1b for MS:Report of a Consensus Conf
Neurol 46:12-18, Lublin,F.D.,et al, 1996
Palliative Care in Neurology
Neurol 46:870-872, 5981996., Bernat,J.L.,et al, 1996
Fatigue Therapy in Multiple Sclerosis:A Double-blind, Randomized, Parallel Trial of Amantadine, Pemoline & Placebo
Neurol 45:1956-1961, Krupp,L.B.,et al, 1995
The Effects of 4-Aminopyridine in MS Pts:Randomized, Placebo-Controlled, Double-Blind, Concentration-Controlled, Crossover
Neurol 44:1054-1059, Bever,C.T.,et al, 1994
Psychological Stress as Risk Factor for Exacerbations in Multiple Sclerosis
Neurol 43:1311-1312, Nisipeanu,P.&Korczyn,A.D., 1993
A Double-Blind, Renadomized, Crossover Trial of Pemoline in Fatigue Assoc with Multiple Sclerosis
Neurol 42:1468-1471, Weinshenker,B.G.,et al, 1992
"Fatigue"in Patients with Multiple Sclerosis
Arch Neurol 49:517-524, Sandroni,P.,et al, 1992
Excessive Muscular Fatigue in Patients with Spastic Paraparesis
Neurol 40:1271-1274, Miller,R.G.,et al, 1990
Severely Threatening Events and Marked Life Difficulties Preceding Onset or Exacerbation of MS
JNNP 52:8-13, Grant,I.,et al, 1989
Amantadine Treatment of Fatigue Associated with Multiple Sclerosis
Arch Neurol 46:676-680, Cohen,R.A.&Fisher,M., 1989
Demyelinating Diseases
In Rowlands Merritt's Textbk of Neurology, Lea & Febiger, Phila, 8th Ed, p. 749, Sibley,W.A.,et al, 1989
Fatigue in Multiple Sclerosis
Arch Neurol 45:435-437, Krupp,L.B.,et al, 1988
Amantadine, Fatigue, and Multiple Sclerosis
Arch Neurol 45:1104-1106, Rosenberg,G.A.&Appenzeller,O., 1988